Erlotinib Completed Phase 1 Trials for Advanced Cancers / Tumors, Solid Treatment

Back to Erlotinib
IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00895362Erlotinib in Combination With Cetuximab
NCT00903734An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status
NCT01532011Erlotinib in Combination With Pralatrexate in Advanced Malignancies
NCT01009073A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects
NCT00495872Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
NCT00770263Erlotinib and Temsirolimus for Solid Tumors